Catalysts for $ABBV
477 tracked
May 15, 2018
approval
OZURDEX (DEXAMETHASONE) — FDA approval
dexamethasone LA
→
Mar 6, 2018
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 6, 2018
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 6, 2018
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Feb 16, 2018
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Feb 16, 2018
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Dec 20, 2017
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Dec 20, 2017
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Dec 14, 2017
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Nov 9, 2017
approval
VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
CARIPRAZINE HYDROCHLORIDE
→
Nov 9, 2017
approval
VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
CARIPRAZINE HYDROCHLORIDE
→
Oct 5, 2017
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Oct 5, 2017
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Oct 5, 2017
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Aug 2, 2017
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Jul 10, 2017
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
May 4, 2017
approval
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Apr 28, 2017
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Apr 21, 2017
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Mar 27, 2017
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Mar 8, 2017
approval
LINZESS (LINACLOTIDE) — FDA approval
linaclotide
→
Mar 6, 2017
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 6, 2017
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 6, 2017
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Feb 23, 2017
approval
VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
CARIPRAZINE HYDROCHLORIDE
→
Jan 25, 2017
approval
LINZESS (LINACLOTIDE) — FDA approval
linaclotide
→
Jan 18, 2017
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Jan 6, 2017
approval
LINZESS (LINACLOTIDE) — FDA approval
linaclotide
→
Nov 2, 2016
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 2, 2016
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→